Announcement on Outline of the Q3 2025 Performance Briefing
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
The meeting will feature interactions between the company's board members and investors, addressing key concerns raised by shareholders. Investors expressed hopes for the company to focus on its core health-related business and improve its marketing efforts. The company acknowledged the challenges of divesting non-core operations and emphasized its commitment to enhancing its main business.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Jilin Quanyangquan Co., Ltd. on 6ix
Earlier from Jilin Quanyangquan
- Announcement on Making Provisions for Asset Impairment
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
Later from Jilin Quanyangquan
- Supplementary Announcement on Holding Subsidiary Winning Bid for Project
- Announcement on Litigation Involving the Wholly-owned Subsidiary
- Announcement on Progress in Project With Contract Awarded by the Holding Subsidiary
- Announcement on the Change in Shareholding Status of Partial Shares Held by Shareholders and Directors with Over 5% Shares
- Notice on Convening the 3rd Extraordinary General Meeting in 2025
Follow Jilin Quanyangquan into a list and get an email when it puts out news.
Follow Jilin Quanyangquan